• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Ideaya Biosciences Inc (NQ: IDYA )

    30.41 +0.83 (+2.81%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Ideaya Biosciences Inc

    < Previous 1 2 3 4 Next >
    This Cognex Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
    Via Benzinga
    Ideaya Biosciences Stock Tumbles Despite Promising Data From Rare Eye Cancer Candidate
    IDEAYA Biosciences released interim Phase 2 data that shows promising tumor shrinkage and eye preservation rates. 
    Via Benzinga
    Oracle To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Tuesday
    Via Benzinga
    IDYA Stock Earnings: IDEAYA Biosciences Misses EPS for Q2 2024
    IDYA stock results show that IDEAYA Biosciences missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    Week In Review: ImmuneOnco Out-Licenses Two Antibodies In $2 Billion Deal
    Shanghai ImmuneOnco Biopharma out-licensed global rites (ex-China) for two of its antibodies to Instil Bio of Dallas, Texas. ImmuneOnco will receive an upfront and near-term payments of $50 million,... 
    Via Talk Markets
    Unveiling 5 Analyst Insights On IDEAYA Biosciences
    Via Benzinga
    Demystifying IDEAYA Biosciences: Insights From 6 Analyst Reviews
    Via Benzinga
    The Analyst Verdict: IDEAYA Biosciences In The Eyes Of 6 Experts
    Via Benzinga
    Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Kura Sushi Posts Weak Q3 Results, Joins LegalZoom.com And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    IDEAYA Biosciences Highlights 'Encouraging' Preliminary Efficacy, Safety Profile For Patients With Hard-To-Treat Cancer
    IDEAYA Biosciences reports promising Phase 2 clinical data for IDE397 in MTAP-deletion urothelial and NSCLC patients. The study shows a 39% overall response rate, 94% disease control rate, and a... 
    Via Benzinga
    Corning Increases Sales Forecast, Joins Morphic Holding, Lucid Group And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Why Ideaya Biosciences Just Made Its Most Bullish Move Since March
    The company is working on a treatment for cancers tied to a genetic alteration called MTAP deletion. 
    Via Investor's Business Daily
    Why Paramount Global Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Recap: IDEAYA Biosciences Q4 Earnings
    Via Benzinga
    The Analyst Verdict: IDEAYA Biosciences In The Eyes Of 8 Experts
    Via Benzinga
    Critical Insights From IDEAYA Biosciences Analyst Ratings: What You Need To Know
    Via Benzinga
    IDYA Stock Earnings: IDEAYA Biosciences Misses EPS for Q1 2024
    IDYA stock results show that IDEAYA Biosciences missed analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    Goldman Sachs Maintains Buy Rating for IDEAYA Biosciences: Here's What You Need To Know
    Via Benzinga
    Chart Of The Day: IDEAYA Biosciences - Oncology Biomedicine
    IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using... 
    Via Talk Markets
    8 Analysts Have This to Say About IDEAYA Biosciences
    Via Benzinga
    The Latest Analyst Ratings for IDEAYA Biosciences
    Via Benzinga
    Why Ideaya Biosciences Stock Is Plummeting Today
    Ideaya stock is getting hit hard following a recent press release from the company. 
    Via The Motley Fool
    Why IDEAYA Biosciences Stock Is Falling During Wednesday's Session
    Ideaya Biosciences Inc (NASDAQ: IDYA) shares are trading lower by 11.6% to $24.10 Wednesday morning after the company priced an underwritten public offering of common stock and pre-funded warrants. 
    Via Benzinga
    Where IDEAYA Biosciences Stands With Analysts
    Via Benzinga
    7 Analysts Have This to Say About IDEAYA Biosciences
    Via Benzinga
    Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ. 
    Via Benzinga
    Alphabet, Texas Instruments, CoStar Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    U.S. stock futures traded mixed this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session. 
    Via Benzinga
    Adobe To Rally Over 14%? Here Are 10 Other Analyst Forecasts For Tuesday
    RBC Capital boosted the price target for CareTrust REIT, Inc. (NYSE: CTRE) from $19 to $23. RBC Capital analyst Michael Carroll upgraded the stock from Sector Perform to Outperform. CareTrust REIT... 
    Via Benzinga
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.